Although the finding did not reach statistical significance, the trend contributed to the hypothesis that DPP-4 inhibitors may adversely affect heart failure outcomes in susceptible patients.
← all excerpts
Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis.
1
—
—